Shanshan Liu

With 15 years of experience in the global pharmaceutical industry, predominantly in Process, CQV, Process Automation and Project Management, Shanshan has held both Consultant and End User roles. With increasing involvement in the GMP remediation and GMP audit projects, she has been building in-depth compliance knowledge as well as interaction with authorities globally.

preventing cross contamination in the pharmaceutical industry no deviation

Preventing cross-contamination in the pharmaceutical industry

Often on projects in the pharmaceutical industry, we are asked various questions regarding cross-contamination prevention. It could be a greenfield project for a multi-products and multi-purpose manufacturing facility, an NPI (New Product Introduction) project in an existing facility, or a compliance remediation project.  There’s no simple answer to questions like, “Can the two products share

Preventing cross-contamination in the pharmaceutical industry Read More »

gmp certification case study back in the state of control no deviation

GMP certification case study: Back in the State of Control

Suspension of a site’s GMP certification imposes substantial stress and impact on business, as well as the potential shortage of market supply.  This case study outlines how the No deviation team supported a China-based biologics manufacturer to bridge the compliance gaps and achieve the ‘State of Control’ – a condition in which the set of

GMP certification case study: Back in the State of Control Read More »

how to provide effective gmp training in the pharma industry no deviation

How to provide effective GMP training in the pharma industry

Article 7.4 of EU Directive 2003/94, which lays down the principles and guidelines of GMP, requires that: ‘The personnel shall receive initial and ongoing training, the effectiveness of which shall be verified,…’ When it comes to designing and delivering GMP training, we take into full consideration that – The depth and length of modules are

How to provide effective GMP training in the pharma industry Read More »

regulation mind map for the pharma industry no deviation

Regulation Mind Map for the pharmaceutical industry

I might be saying it too often: the pharmaceutical industry is highly regulated. But what regulates our practices? It could be federal codes, regulations, directives or even guidance. There are national or regional legislations and there are international harmonisations. For anyone working in this arena or for anyone working in the industry, how do we

Regulation Mind Map for the pharmaceutical industry Read More »

pharmaceutical packaging operations and distribution no deviation

Pharmaceutical Packaging: a critical aspect to ensure patient safety – Part 2

Following the discussion in Part 1, which covered Pharmaceutical Packaging – Quality by Design, this part will look into Procedures, which is also a Critical Design Element (CDE) besides Equipment and Facility. Without procedures, the ‘State of Control’ is impossible to achieve. For instance, equipment will not be maintained in the ‘qualified status’. As another

Pharmaceutical Packaging: a critical aspect to ensure patient safety – Part 2 Read More »

pharmaceutical packaging and quality by design no deviation

Pharmaceutical Packaging: a critical aspect to ensure patient safety – Part 1

Background Working in the pharmaceutical industry, ‘recall’ might be one of the words nobody wants to hear. It could indicate a series of consequences, from critical ones of harming patient safety to major ones of tarnishing a company’s reputation. Unfortunately, despite the regulators’ and industry’s best efforts, pharmaceutical packaging remains one of the principal reasons

Pharmaceutical Packaging: a critical aspect to ensure patient safety – Part 1 Read More »